Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Intravenous Peramivir in High-Risk Patients With Influenza Virus Infection
jRCT2080220737Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of peramivir in influenza, sponsored by Shionogi & Co., Ltd.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080220737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220737.